about
Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy.Viral inactivation of fresh frozen plasma.The use of chromatography to manufacture purer and safer plasma products.Age-specific antibody prevalence to hepatitis A in England: implications for disease controlModern treatment of haemophiliaA nonenveloped virus with a lipid envelope: hepatitis A virus as used in virus-reduction studies.Considerations for current and future management of haemophilia and its complications.Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assay.Safety and efficacy of solvent/detergent-treated antihaemophilic factor with an added 80 degrees C terminal dry heat treatment in patients with haemophilia A.Hepatitis A virus infection. No conclusive link to factor VIII.Implementation of a hepatitis A prevention policy in haemophiliacs: results from the French cohort.Causality assessment of suspected virus transmission by human plasma products.Pharmacokinetics and acute tolerance of a double virus inactivated plasma derived factor VIII concentrate.A new cluster of hepatitis A infection in hemophiliacs traced to a contaminated plasma pool.Hepatitis A transmission by factor IX concentrates.Recommendations for postmarketing surveillance studies in haemophilia and other bleeding disorders.A post-marketing safety and efficacy assessment of a monoclonal antibody purified high-purity factor VIII concentrate.Hepatitis A immunization in HIV-infected haemophilic patients.Viral safety of plasma-derived and recombinant products used in the management of haemophilia A and B.Management of patients with HIV and/or hepatitis.
P2860
Q33815761-AA31142D-7207-4FBE-A6EF-049E09628E0EQ33992794-31A7B4AE-27E6-4A9E-A6F6-BFE0754D94ECQ34187883-CEC27E41-54C3-4423-BA78-15ECF83C2471Q36503452-50569A92-246F-473F-9C8A-C03869A963EAQ36794921-5DAD7640-344A-4D7E-9152-D1417A12FFE8Q40261436-400CD8D4-9F3F-4AE1-BA3B-EFA921A34382Q40998209-642D657F-0BBF-4BA3-8C5C-18933A18A58DQ41201363-6F6DBDFD-CDEA-4EB7-A84D-C52A0257597DQ41733580-4649624C-96CE-44A3-BFFA-26DDF3A02C86Q43152043-6E001317-8D47-4C5C-85B1-3C264C28C75BQ45084513-12B6F9A5-BC8F-4C57-B77F-C18070446E53Q45736204-25C06178-D9A4-4D13-B2AD-551FCD9B3E46Q45747498-FD487F02-9AC5-4249-AC8B-2B544DEADA44Q45855627-176C0821-BE7A-4C52-8C8C-598900BE19AFQ45879111-6E369E0A-DB5F-4801-8EF4-49FF222E771DQ45884954-3588CA9B-4FFF-43B9-89CA-6434D3676D94Q45886474-8C396D5E-53D9-43A7-B6D7-5BDC8C6BFA71Q45886856-47396AF0-174A-4D80-B70A-F9218C05F411Q45887091-DF120DED-AE9E-4C6B-936D-38440B0F1C21Q45887104-D16AAEBE-0779-4DE3-8A9E-9B1E730026E1
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Acute hepatitis A in patients with haemophilia A.
@en
Acute hepatitis A in patients with haemophilia A.
@nl
type
label
Acute hepatitis A in patients with haemophilia A.
@en
Acute hepatitis A in patients with haemophilia A.
@nl
prefLabel
Acute hepatitis A in patients with haemophilia A.
@en
Acute hepatitis A in patients with haemophilia A.
@nl
P1433
P1476
Acute hepatitis A in patients with haemophilia A.
@en
P2093
J Vermylen
K Peerlinck
P356
10.1016/0140-6736(93)90044-H
P407
P577
1993-01-01T00:00:00Z